This fits with the observation we made in the NSCLC cohort, where PAEP was overexpressed in more than 80% of all tumors but was much less detectable in sera of pretherapeutical NSCLC patients [28]. The gene discussed is PAEP; the disease is non-small cell lung carcinoma.